Skip to main content
Top
Published in: BMC Geriatrics 1/2023

Open Access 01-12-2023 | Stroke | Research

The impact of stroke on the ability to live an independent life at old age: a community-based cohort study of Swedish men

Authors: Elias Lindvall, Kristin Franzon, Erik Lundström, Lena Kilander

Published in: BMC Geriatrics | Issue 1/2023

Login to get access

Abstract

Introduction

Few studies with controls from the same cohort have investigated the impact of stroke on the ability to live an independent life at old age. We aimed to analyze how great an impact being a stroke survivor would have on cognition and disability. We also analyzed the predictive value of baseline cardiovascular risk factors.

Methods

We included 1147 men, free from stroke, dementia, and disability, from the Uppsala Longitudinal Study of Adult Men, between 69–74 years of age. Follow-up data were collected between the ages of 85–89 years and were available for 481 of all 509 survivors. Data on stroke diagnosis were obtained through national registries. Dementia was diagnosed through a systematic review of medical charts and in accordance with the current diagnostic criteria. The primary outcome, preserved functions, was a composite outcome comprising four criteria: no dementia, independent in personal activities of daily living, ability to walk outside unassisted, and not living in an institution.

Results

Among 481 survivors with outcome data, 64 (13%) suffered a stroke during the follow-up. Only 31% of stroke cases, compared to 72% of non-stroke cases (adjusted OR 0.20 [95% CI 0.11–0.37]), had preserved functions. The chance of being free of dementia was 60% lower in the stroke group, OR 0.40 [95% CI 0.22–0.72]. No cardiovascular risk factors were independently able to predict preserved functions among stroke cases.

Conclusion

Stroke has long lasting consequences for many aspects of disability at very high age.
Appendix
Available only for authorised users
Literature
1.
go back to reference Feigin VL, Stark BA, Johnson CO, et al. Global, regional, and national burden of stroke and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Neurol. 2021;20:795–820.CrossRef Feigin VL, Stark BA, Johnson CO, et al. Global, regional, and national burden of stroke and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Neurol. 2021;20:795–820.CrossRef
2.
go back to reference Lackland DT, Roccella EJ, Deutsch AF, et al. Factors Influencing the Decline in Stroke Mortality: A Statement From the American Heart Association/American Stroke Association. Stroke. 2014;45:315–53.PubMedCrossRef Lackland DT, Roccella EJ, Deutsch AF, et al. Factors Influencing the Decline in Stroke Mortality: A Statement From the American Heart Association/American Stroke Association. Stroke. 2014;45:315–53.PubMedCrossRef
3.
go back to reference Veerbeek JM, Kwakkel G, van Wegen EEH, et al. Early Prediction of Outcome of Activities of Daily Living After Stroke: A Systematic Review. Stroke. 2011;42:1482–8.PubMedCrossRef Veerbeek JM, Kwakkel G, van Wegen EEH, et al. Early Prediction of Outcome of Activities of Daily Living After Stroke: A Systematic Review. Stroke. 2011;42:1482–8.PubMedCrossRef
4.
go back to reference Pendlebury ST, Rothwell PM. Incidence and prevalence of dementia associated with transient ischaemic attack and stroke: analysis of the population-based Oxford Vascular Study. Lancet Neurol. 2019;18:248–58.PubMedPubMedCentralCrossRef Pendlebury ST, Rothwell PM. Incidence and prevalence of dementia associated with transient ischaemic attack and stroke: analysis of the population-based Oxford Vascular Study. Lancet Neurol. 2019;18:248–58.PubMedPubMedCentralCrossRef
5.
go back to reference O’Brien JT, Erkinjuntti T, Reisberg B, et al. Vascular cognitive impairment. Lancet Neurol. 2003;2:89–98.PubMedCrossRef O’Brien JT, Erkinjuntti T, Reisberg B, et al. Vascular cognitive impairment. Lancet Neurol. 2003;2:89–98.PubMedCrossRef
6.
go back to reference Azarpazhooh MR, Avan A, Cipriano LE, et al. Concomitant vascular and neurodegenerative pathologies double the risk of dementia. Alzheimers Dement. 2018;14:148–56.PubMedCrossRef Azarpazhooh MR, Avan A, Cipriano LE, et al. Concomitant vascular and neurodegenerative pathologies double the risk of dementia. Alzheimers Dement. 2018;14:148–56.PubMedCrossRef
7.
go back to reference Hofman C, Makai P, Boter H, et al. The influence of age on health valuations: the older olds prefer functional independence while the younger olds prefer less morbidity. Clin Interv Aging. 2015;10:1131–9.PubMedPubMedCentralCrossRef Hofman C, Makai P, Boter H, et al. The influence of age on health valuations: the older olds prefer functional independence while the younger olds prefer less morbidity. Clin Interv Aging. 2015;10:1131–9.PubMedPubMedCentralCrossRef
8.
go back to reference Franzon K, Byberg L, Sjögren P, et al. Predictors of Independent Aging and Survival: A 16-Year Follow-Up Report in Octogenarian Men. J Am Geriatr Soc. 2017;65:1953–60.PubMedCrossRef Franzon K, Byberg L, Sjögren P, et al. Predictors of Independent Aging and Survival: A 16-Year Follow-Up Report in Octogenarian Men. J Am Geriatr Soc. 2017;65:1953–60.PubMedCrossRef
9.
go back to reference Hedstrand H. A study of middle-aged men with particular reference to risk factors for cardiovascular disease. Ups J Med Sci Suppl. 1975;19:1–61.PubMed Hedstrand H. A study of middle-aged men with particular reference to risk factors for cardiovascular disease. Ups J Med Sci Suppl. 1975;19:1–61.PubMed
10.
go back to reference American Diabetes Association. 2. Classification and Diagnosis of Diabetes. Diabetes Care. 2015;38:S8–16.CrossRef American Diabetes Association. 2. Classification and Diagnosis of Diabetes. Diabetes Care. 2015;38:S8–16.CrossRef
11.
go back to reference Williams B, Mancia G, Spiering W, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension. J Hypertens. 2018;36:1953–2041.PubMedCrossRef Williams B, Mancia G, Spiering W, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension. J Hypertens. 2018;36:1953–2041.PubMedCrossRef
12.
go back to reference Folstein MF, Folstein SE, McHugh PR. ‘Mini-mental state’. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189–98.PubMedCrossRef Folstein MF, Folstein SE, McHugh PR. ‘Mini-mental state’. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189–98.PubMedCrossRef
13.
go back to reference Solomon PR, Hirschoff A, Kelly B, et al. A 7 Minute Neurocognitive Screening Battery Highly Sensitive to Alzheimer’s Disease. Arch Neurol. 1998;55:349.PubMedCrossRef Solomon PR, Hirschoff A, Kelly B, et al. A 7 Minute Neurocognitive Screening Battery Highly Sensitive to Alzheimer’s Disease. Arch Neurol. 1998;55:349.PubMedCrossRef
14.
go back to reference Lezak M. Neuropsychological assessment. 3rd ed. New York: Oxford University Press; 1995. Lezak M. Neuropsychological assessment. 3rd ed. New York: Oxford University Press; 1995.
15.
go back to reference Quan H, Sundararajan V, Halfon P, et al. Coding Algorithms for Defining Comorbidities in ICD-9-CM and ICD-10 Administrative Data. Med Care. 2005;43:1130–9.PubMedCrossRef Quan H, Sundararajan V, Halfon P, et al. Coding Algorithms for Defining Comorbidities in ICD-9-CM and ICD-10 Administrative Data. Med Care. 2005;43:1130–9.PubMedCrossRef
16.
go back to reference Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373–83.PubMedCrossRef Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373–83.PubMedCrossRef
17.
go back to reference McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer’s disease: Report of the NINCDS-ADRDA Work Group* under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease. Neurology. 1984;34:939–939.PubMedCrossRef McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer’s disease: Report of the NINCDS-ADRDA Work Group* under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease. Neurology. 1984;34:939–939.PubMedCrossRef
18.
go back to reference Chui HC, Victoroff JI, Margolin D, et al. Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer’s Disease Diagnostic and Treatment Centers. Neurology. 1992;42:473–473.PubMedCrossRef Chui HC, Victoroff JI, Margolin D, et al. Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer’s Disease Diagnostic and Treatment Centers. Neurology. 1992;42:473–473.PubMedCrossRef
19.
go back to reference McKeith IG. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): Report of the Consortium on DLB International Workshop. J Alzheimers Dis. 2006;9:417–23.PubMedCrossRef McKeith IG. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): Report of the Consortium on DLB International Workshop. J Alzheimers Dis. 2006;9:417–23.PubMedCrossRef
20.
go back to reference Martinez-Martin P, Falup-Pecurariu C, Rodriguez-Blazquez C, et al. Dementia associated with Parkinson’s disease: Applying the Movement Disorder Society Task Force criteria. Parkinsonism Relat Disord. 2011;17:621–4.PubMedCrossRef Martinez-Martin P, Falup-Pecurariu C, Rodriguez-Blazquez C, et al. Dementia associated with Parkinson’s disease: Applying the Movement Disorder Society Task Force criteria. Parkinsonism Relat Disord. 2011;17:621–4.PubMedCrossRef
21.
go back to reference McKhann GM. Clinical and Pathological Diagnosis of Frontotemporal Dementia: Report of the Work Group on Frontotemporal Dementia and Pick’s Disease. Arch Neurol. 2001;58:1803.PubMedCrossRef McKhann GM. Clinical and Pathological Diagnosis of Frontotemporal Dementia: Report of the Work Group on Frontotemporal Dementia and Pick’s Disease. Arch Neurol. 2001;58:1803.PubMedCrossRef
22.
go back to reference Cruz-Jentoft AJ, Bahat G, Bauer J, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019;48:16–31.PubMedCrossRef Cruz-Jentoft AJ, Bahat G, Bauer J, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019;48:16–31.PubMedCrossRef
23.
go back to reference Bohannon RW, Leary KM. Standing balance and function over the course of acute rehabilitation. Arch Phys Med Rehabil. 1995;76:994–6.PubMedCrossRef Bohannon RW, Leary KM. Standing balance and function over the course of acute rehabilitation. Arch Phys Med Rehabil. 1995;76:994–6.PubMedCrossRef
24.
go back to reference Podsiadlo D, Richardson S. The Timed “Up & Go”: A Test of Basic Functional Mobility for Frail Elderly Persons. J Am Geriatr Soc. 1991;39:142–8.PubMedCrossRef Podsiadlo D, Richardson S. The Timed “Up & Go”: A Test of Basic Functional Mobility for Frail Elderly Persons. J Am Geriatr Soc. 1991;39:142–8.PubMedCrossRef
25.
go back to reference Gottfries GG, Noltorp S, Nørgaard N. Experience with a Swedish version of the Geriatric Depression Scale in primary care centres. Int J Geriatr Psychiatry. 1997;12:1029–34.PubMedCrossRef Gottfries GG, Noltorp S, Nørgaard N. Experience with a Swedish version of the Geriatric Depression Scale in primary care centres. Int J Geriatr Psychiatry. 1997;12:1029–34.PubMedCrossRef
26.
go back to reference de Boer AGEM, van Lanschot JJB, Stalmeier PFM, et al. Is a single-item visual analogue scale as valid, reliable and responsive as multi-item scales in measuring quality of life? Qual Life Res. 2004;13:311–20.PubMedCrossRef de Boer AGEM, van Lanschot JJB, Stalmeier PFM, et al. Is a single-item visual analogue scale as valid, reliable and responsive as multi-item scales in measuring quality of life? Qual Life Res. 2004;13:311–20.PubMedCrossRef
27.
go back to reference Klompstra L, Ekdahl AW, Krevers B, et al. Factors related to health-related quality of life in older people with multimorbidity and high health care consumption over a two-year period. BMC Geriatr. 2019;19:187.PubMedPubMedCentralCrossRef Klompstra L, Ekdahl AW, Krevers B, et al. Factors related to health-related quality of life in older people with multimorbidity and high health care consumption over a two-year period. BMC Geriatr. 2019;19:187.PubMedPubMedCentralCrossRef
28.
go back to reference Pendlebury ST, Rothwell PM. Prevalence, incidence, and factors associated with pre-stroke and post-stroke dementia: a systematic review and meta-analysis. Lancet Neurol. 2009;8:1006–18.PubMedCrossRef Pendlebury ST, Rothwell PM. Prevalence, incidence, and factors associated with pre-stroke and post-stroke dementia: a systematic review and meta-analysis. Lancet Neurol. 2009;8:1006–18.PubMedCrossRef
29.
30.
go back to reference Ivan CS, Seshadri S, Beiser A, et al. Dementia After Stroke: The Framingham Study. Stroke. 2004;35:1264–8.PubMedCrossRef Ivan CS, Seshadri S, Beiser A, et al. Dementia After Stroke: The Framingham Study. Stroke. 2004;35:1264–8.PubMedCrossRef
31.
go back to reference Jin Y, Di Legge S, Ostbye T, et al. The reciprocal risks of stroke and cognitive impairment in an elderly population. Alzheimers Dement. 2006;2:171–8.PubMedCrossRef Jin Y, Di Legge S, Ostbye T, et al. The reciprocal risks of stroke and cognitive impairment in an elderly population. Alzheimers Dement. 2006;2:171–8.PubMedCrossRef
32.
go back to reference Zhu L, Fratiglioni L, Guo Z, et al. Incidence of Dementia in Relation to Stroke and the Apolipoprotein E ε4 Allele in the Very Old: Findings From a Population-Based Longitudinal Study. Stroke. 2000;31:53–60.PubMedCrossRef Zhu L, Fratiglioni L, Guo Z, et al. Incidence of Dementia in Relation to Stroke and the Apolipoprotein E ε4 Allele in the Very Old: Findings From a Population-Based Longitudinal Study. Stroke. 2000;31:53–60.PubMedCrossRef
33.
go back to reference Sigurdsson S, Aspelund T, Kjartansson O, et al. Incidence of Brain Infarcts, Cognitive Change, and Risk of Dementia in the General Population: The AGES-Reykjavik Study (Age Gene/Environment Susceptibility-Reykjavik Study). Stroke. 2017;48:2353–60.PubMedPubMedCentralCrossRef Sigurdsson S, Aspelund T, Kjartansson O, et al. Incidence of Brain Infarcts, Cognitive Change, and Risk of Dementia in the General Population: The AGES-Reykjavik Study (Age Gene/Environment Susceptibility-Reykjavik Study). Stroke. 2017;48:2353–60.PubMedPubMedCentralCrossRef
34.
go back to reference Reitz C, Bos MJ, Hofman A, et al. Prestroke Cognitive Performance, Incident Stroke, and Risk of Dementia: The Rotterdam Study. Stroke. 2008;39:36–41.PubMedCrossRef Reitz C, Bos MJ, Hofman A, et al. Prestroke Cognitive Performance, Incident Stroke, and Risk of Dementia: The Rotterdam Study. Stroke. 2008;39:36–41.PubMedCrossRef
36.
go back to reference Quinn TJ, Dawson J, Walters MR, et al. Functional Outcome Measures in Contemporary Stroke Trials. Int J Stroke. 2009;4:200–5.PubMedCrossRef Quinn TJ, Dawson J, Walters MR, et al. Functional Outcome Measures in Contemporary Stroke Trials. Int J Stroke. 2009;4:200–5.PubMedCrossRef
37.
go back to reference Appelros P, Nydevik I, Terent A. Living setting and utilisation of ADL assistance one year after a stroke with special reference to gender differences. Disabil Rehabil. 2006;28:43–9.PubMedCrossRef Appelros P, Nydevik I, Terent A. Living setting and utilisation of ADL assistance one year after a stroke with special reference to gender differences. Disabil Rehabil. 2006;28:43–9.PubMedCrossRef
38.
go back to reference Luengo-Fernandez R, Paul NLM, Gray AM, et al. Population-Based Study of Disability and Institutionalization After Transient Ischemic Attack and Stroke: 10-Year Results of the Oxford Vascular Study. Stroke. 2013;44:2854–61.PubMedPubMedCentralCrossRef Luengo-Fernandez R, Paul NLM, Gray AM, et al. Population-Based Study of Disability and Institutionalization After Transient Ischemic Attack and Stroke: 10-Year Results of the Oxford Vascular Study. Stroke. 2013;44:2854–61.PubMedPubMedCentralCrossRef
39.
go back to reference Tiel C, Sudo FK, Calmon AB. Neuropsychiatric symptoms and executive function impairments in Alzheimer’s disease and vascular dementia: The role of subcortical circuits. Dement Neuropsychol. 2019;13:293–8.PubMedPubMedCentralCrossRef Tiel C, Sudo FK, Calmon AB. Neuropsychiatric symptoms and executive function impairments in Alzheimer’s disease and vascular dementia: The role of subcortical circuits. Dement Neuropsychol. 2019;13:293–8.PubMedPubMedCentralCrossRef
40.
go back to reference Levine DA, Wadley VG, Langa KM, et al. Risk Factors for Poststroke Cognitive Decline: The REGARDS Study (Reasons for Geographic and Racial Differences in Stroke). Stroke. 2018;49:987–94.PubMedPubMedCentralCrossRef Levine DA, Wadley VG, Langa KM, et al. Risk Factors for Poststroke Cognitive Decline: The REGARDS Study (Reasons for Geographic and Racial Differences in Stroke). Stroke. 2018;49:987–94.PubMedPubMedCentralCrossRef
41.
go back to reference Cucchiara B, George DK, Kasner SE, et al. Disability after minor stroke and TIA: A secondary analysis of the SOCRATES trial. Neurology. 2019;93:e708–16.PubMedCrossRef Cucchiara B, George DK, Kasner SE, et al. Disability after minor stroke and TIA: A secondary analysis of the SOCRATES trial. Neurology. 2019;93:e708–16.PubMedCrossRef
42.
go back to reference Douiri A, Rudd AG, Wolfe CDA. Prevalence of Poststroke Cognitive Impairment: South London Stroke Register 1995–2010. Stroke. 2013;44:138–45.PubMedCrossRef Douiri A, Rudd AG, Wolfe CDA. Prevalence of Poststroke Cognitive Impairment: South London Stroke Register 1995–2010. Stroke. 2013;44:138–45.PubMedCrossRef
Metadata
Title
The impact of stroke on the ability to live an independent life at old age: a community-based cohort study of Swedish men
Authors
Elias Lindvall
Kristin Franzon
Erik Lundström
Lena Kilander
Publication date
01-12-2023
Publisher
BioMed Central
Published in
BMC Geriatrics / Issue 1/2023
Electronic ISSN: 1471-2318
DOI
https://doi.org/10.1186/s12877-023-03817-1

Other articles of this Issue 1/2023

BMC Geriatrics 1/2023 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine